MPM BioImpact
mpmbioimpact.com Direct investor
MPM BioImpact is a biotechnology investment firm that builds and invests in companies across all stages of drug development, with a focus on transforming scientific breakthroughs into life-saving medicines. It manages over $3 billion in assets across early-stage venture funds, private/public impact funds, and a public equities fund.
MPM BioImpact is a venture capital firm headquartered in Boston, United States. It invests directly in companies, from seed to growth, in biotechnology, drug development, oncology and immunology. Over $3 billion under management, as it reports.
“We invest in private and public companies across the drug development process with the goal of transforming scientific breakthroughs into life saving medicines.”
— MPM BioImpact, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- Boston, United States
- Sectors
- biotechnology, drug development, oncology, immunology, neuroscience, radiopharmaceuticals, RNA therapeutics
- Assets under management
- over $3 billion
Team, as MPM BioImpact publishes it
- Christiana Bardon Managing Partner
- Ansbert Gadicke Chairman
- Detlev Biniszkiewicz Managing Director
- Todd Foley Managing Director
- Pankaj Bhargava Entrepreneur Partner
- Frank Neumann Entrepreneur Partner
- Briggs Morrison Entrepreneur Partner
- Matthew Roden Entrepreneur Partner
- Aparna Parikh Entrepreneur Partner
- Rami Rahal Partner
- Andrew M. Scharenberg Entrepreneur Partner
- Kristen Laguerre Investment Team
Names and roles exactly as listed on mpmbioimpact.com. Nothing else about these people is recorded.
Most shared portfolio companies with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 189 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.
- Vida Ventures 4 shared companies: recodetx.com, dyne-tx.com, aktisoncology.com, protegobiopharma.com
- EcoR1 Capital 3 shared companies: recodetx.com, aktisoncology.com, elevate.bio
- Leaps by Bayer 2 shared companies: nextpointtx.com, recodetx.com
- TCG Crossover Management, LLC 2 shared companies: aktisoncology.com, entradatx.com
- Abac Capital 1 shared company: goo.gl
- Abingworth 1 shared company: goo.gl
- AC Ventures 1 shared company: goo.gl
- Acrewood Holdings 1 shared company: goo.gl
- Adara Ventures 1 shared company: goo.gl
- Adit Ventures Management, LLC 1 shared company: goo.gl
and 179 more — the graph.
Where this comes from
Every fact above was read from a page MPM BioImpact publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://mpmbioimpact.com//name, is_investor, hq_country, hq_city, sectors, thesis_quote, thesis_quote_page, layer
- https://mpmbioimpact.com/about/layer, type, description, aum
- https://mpmbioimpact.com/portfolio/stage_min, stage_max
- https://mpmbioimpact.com/team/people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 1365 · added 2026-08-28 · link last verified 2026-10-21 · confidence high
Similar investors
- Atlas VentureVenture capital · Seed – Series A · Cambridge, United States
- 7G BioVenturesVenture capital · Burlingame, United States
- Agent Capital, LLCVenture capital · Seed – Growth · Waltham, United States
- AMR Action FundVenture capital · Boston, United States
- Blindspot Ventures Management CoVenture capital · Pre-seed – Seed · Boston, United States
- Cure Ventures Management, LPVenture capital · Seed · Boston, United States